Suven Pharmaceuticals

BSE : 543064 | NSE : SUVENPHAR
Industry : Pharmaceuticals | ISIN : INE03QK01018 | FreeFloat : 37.57% | FnO : No | LotSize : N/A
Intellectual Capital (IC)5,686.38
Net Worth (NW)1,610.78
Intrinsic Worth (IW)7,297.16
Market Cap (MC)12,598.42
Economic Value Added53.90
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)77.93%
IC Gross Margin (EBITDA/IC)12.54%
IC Net Margin (NPT/IC)7.70%
Knowledge Turnover (Sales/IC)0.26
Market to Intrinsic Value (MC/IW)1.73
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 286.65Rs. 494.90
20 Mar 2023 ---- Rs. 470.30
-2.75     -0.58%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 474.85SellAvoid
KB > 50% : Yes50 DMA : Rs. 485.24
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
184.76
190.10
77.34
70.29
68.41
53.21
74.18
Jun-20
C
238.23
243.97
128.14
121.07
117.87
91.52
91.32
Sep-20
C
237.39
237.74
107.60
100.10
96.84
74.08
74.08
Dec-20
C
274.93
279.78
158.99
150.23
147.50
113.63
113.63
Mar-21
C
259.16
262.46
115.65
107.34
105.47
83.12
83.12
Jun-21
C
263.80
269.58
144.04
135.05
132.92
105.08
105.08
Sep-21
C
300.99
306.03
144.28
135.10
133.93
96.98
96.98
Dec-21
C
391.59
456.27
250.71
240.20
239.46
160.07
160.07
Mar-22
C
363.85
380.72
173.89
163.47
161.28
91.67
91.67
Jun-22
C
338.80
349.83
161.92
150.41
148.96
107.54
107.54
Sep-22
C
278.40
289.32
110.80
98.77
98.48
72.06
72.06
Dec-22
C
353.77
366.78
159.71
147.47
146.08
107.72
107.72
* C - Consolidated, S - Standalone